Resources
The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Translational & Preclinical Development
Host Cell Protein & Bioprocessing Reagent Development - Rockland
Translational & Preclinical Development
Preclinical Strategies for Combination Immunotherapies
Oncology is almost always oriented towards simultaneous treatment options. We explore why as well as the approach’s unique challenges.
Translational & Preclinical Development
AAV Gene Therapy and CAR T Therapies: Immunogenicity and Immunoassay Development
Dr. Vibha Jawa, Executive Director, Nonclinical Disposition and Bioanalysis at BMS
Translational & Preclinical Development
Investigating the Core Tenet of Immunotherapy: MHC-I Peptide-Receptor Complexes
Axel Ducret, a Roche Senior Principal Scientist, takes us through his work on one of the most important cellular mechanisms in immunotherapy.
Translational & Preclinical Development
The Future of CAR T for Solid Tumours: Antigen Discovery, Persistence, and Fitness
CAR T, the rockstar therapy of immuno-oncology, finds its next big challenge in translating research for use in solid tumours.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things immuno